Financial toxicity: cancer treatment’s side effect

The shock and anxiety of a cancer diagnosis can be followed by a second jolt: the astronomical price of cancer drugs

Presented by Arjun Rajagopalan,
uploaded on SlideShare. Watch it full screen.

The mechanism by which a drug’s market price is fixed is opaque and mostly arbitrary. Medical research, particularly new drug discovery, is a very expensive endeavour; the drug industry uses this argument to price new drugs at levels that are breathtakingly high. With the backing of currently enforced patent protection laws, drug companies can insulate themselves against market forces that are operational in most other consumer markets where competition assures reasonable prices. The Indian drug industry which used to pride itself on its ability to reverse engineer and deliver generics substitutes at low prices, can no longer indulge in this tactic.

Cancer treatment is a large area of interest for drug research. Unlike other noncommunicable diseases like hypertension, diabetes and the like, patients with a diagnosis of cancer are usually keen to seek the best available treatments. Newer generations of cancer drugs are priced at astounding figures. Treatment costs can exceed 100,000 US dollars a year. Even for those in wealthy, developed nations, the burden can lead to far reaching domains: a complication that has been labeled as “financial toxicity”.

Merci Fée Carabosse

Mon cadeau de naissance, vu par Jiho

Festival de dessins d’humour à Labouheyre ; un dessin d’Olivier Jiho (qui connait bien les effets secondaires des médicaments)…

Le Distilbène DES, en savoir plus

The WONDER DRUG Script, by Caitlin McCarthy

Fingers crossed WONDER DRUG is produced soon !

The influential Black List is promoting WONDER DRUG as a “Featured Script” to the Hollywood industry.

“This script would be perfect for awards season, and with the right casting, it’s easy to see it finding success at the box office.”

DES DiEthylStilbestrol Resources

A Gynecologists’ Guide to DES Daughter Care

Dr Guide For DES Daughters 2015

What DES Daughters and their doctors need to know about the lifelong risks of DES exposure to have a discussion about DES health and needs and concerns.

DES DiEthylStilbestrol Resources

European Carpet Market

What are the health impacts of toxic chemicals possibly present in carpets ?

Swept under the rug: new report reveals toxics in European carpets threatening health, environment and circular economy.

Distilbène® 1mg

“Affections sévères de la prostate”… image credit Réseau DES France

Le Diethylstilbestrol ou DES a été commercialisé via de nombreux noms tels que le Distilbène®, Stilbetin®, Stilboestrol-Borne®, Benzestrol®, Chlorotrianisene®, Estrobene® et Estrosyn® par exemple.

Nombre de sociétés ont promu et vendu leur médicament DES sous plus de 200 noms de marque différents.

Il est toujours prescrit pour certaines affections sévères de la prostate.

Images de médicaments DES

Le Distilbène DES, en savoir plus

Dépliant Réseau DES France 2018 (page 1)

Une présentation claire du DES, néfaste pour 3 générations

Téléchargez et diffusez ce nouveau dépliant de l’association Réseau DES France autour de vous !

Le Distilbène DES, en savoir plus